hospital-acquired infection
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
University of Pittsburgh researchers showed that real-time pathogen whole-genome sequencing can help curb healthcare-associated infections within a hospital.
DiaSorin to Acquire Luminex for $1.8B
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.
Biotia Raises $2.4M in Seed Financing
The startup company will use the money to develop its microbial tests and AI-based software for surveillance and prevention of hospital-acquired infections.